Sort by
Keyphrases
Weight Gain
100%
Antipsychotics
100%
Meta-analysis
100%
Metformin
100%
Systematic Meta-analysis
100%
Attenuation
100%
Placebo
22%
Second-generation Antipsychotics
22%
No Significant Difference
11%
Placebo Groups
11%
Cochrane Database
11%
Embase
11%
Clinically Significant
11%
PubMed
11%
Pharmacological Treatment
11%
Potential Gains
11%
Cholesterol
11%
United States
11%
Clinical Setting
11%
People with Schizophrenia
11%
Subgroup Analysis
11%
Fasting Plasma Glucose
11%
Nave
11%
Metabolic Syndrome
11%
Sensitivity Analysis
11%
Australia
11%
Triglyceride Level
11%
Derangement
11%
Metabolic Derangements
11%
CINAHL
11%
Antipsychotic-induced Weight Gain
11%
China
11%
Metabolic Parameters
11%
Total Triglyceride
11%
Adverse Drug Reaction
11%
Reducing Weight
11%
Cardiometabolic Outcomes
11%
Venezuela
11%
China National Knowledge Infrastructure
11%
Adverse-drug-reactions-incidence
11%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Glycon
100%
Drug Therapy
55%
Placebo
33%
Adverse Drug Reaction
22%
Triacylglycerol
11%
Metabolic Syndrome
11%
Subgroup Analysis
11%
Obesity
11%
Typical Antipsychotic
11%
Body Weight Loss
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Metformin
100%
Placebo
27%
Adverse Drug Reaction
18%
Triacylglycerol
9%
Obesity
9%
Metabolic Syndrome X
9%